Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly population

International Journal of Epidemiology
U SankilampiM Leinonen

Abstract

Pneumococcal infections are a common cause of morbidity and mortality among elderly people. Protection against pneumococcal infections is mediated by serotype-specific antibodies to capsular polysaccharides. To obtain an estimate of anti-pneumococcal immunity, prevalence and levels of pneumococcal antibodies were studied in an unvaccinated elderly population. IgG antibodies to pneumococcal serotypes 3, 6A, and B and to cell wall polysaccharide (C-PS, a common antigen to all pneumococci) were measured by enzyme immuno-assay in 480 subjects aged 64-97 years (206 men, 274 women) who were a random sample (41%) of elderly inhabitants in a semirural community in Finland. An average of 10% of the elderly lacked antibodies to serotypes 3, 6A, and 8, and 62% of the elderly had them in low titres only. Anti-C-PS antibodies were found in 99% of the elderly, and in significantly higher titres than anti-capsular antibodies. Antibody titres to C-PS and to type 6A decreased with age. Elderly women had significantly lower antibody levels than men. Among the men, current smokers had higher antibody titres than non-smokers; in the women, this analysis was not possible because of infrequent history of smoking. The effect of smoking on antibody ti...Continue Reading

Citations

Nov 6, 2003·Psychological Bulletin·Peter P VitalianoJames M Scanlan
Mar 9, 2000·The New England Journal of Medicine·J P NuortiR F Breiman
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark B Loeb
Apr 15, 2003·Clinical Microbiology Reviews·Andrew S ArtzDan L Longo
Aug 12, 2014·Semergen·F Casas MaldonadoD A Vargas Ortega
Dec 26, 2015·American Journal of Preventive Medicine·Michael B SteinbergCristine D Delnevo
Jul 28, 2015·Annals of the New York Academy of Sciences·Nely Rodriguez-ZhurbenkoAna Maria Hernandez
Oct 28, 2008·The Journal of Allergy and Clinical Immunology·Nathaniel D HareZuhair K Ballas
Mar 27, 2003·Journal of the American Geriatrics Society·Mark B Loeb
Apr 22, 2004·Clinics in Chest Medicine·Aymarah M Robles, Deborah Shure
May 10, 2005·Medicine·Mohammed Reza ShariatzadehThomas J Marrie
Jun 8, 2001·Drugs & Aging·J B Rubins, E N Janoff
Jun 21, 2019·Basic & Clinical Pharmacology & Toxicology·Nesrin TarbiahLucy C Fairclough
Feb 24, 2017·Expert Review of Respiratory Medicine·Charles FeldmanTheresa Rossouw
Oct 20, 2001·Journal of Applied Physiology·M D Lockshin
Dec 18, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chen WangScott D Boyd
Mar 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Axel JeurissenXavier Bossuyt
Aug 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuhui ShiKazunaga Agematsu
Feb 10, 2021·Expert Review of Clinical Pharmacology·Maria Gabriella MateraMario Cazzola
Apr 6, 2021·Frontiers in Physiology·Jianghua XieYanhui Zou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.